Evaluation of Factor Vlll Deficient Plasmas

 

PDF Download Buy Article Permissions and Reprints

Summary

Immunodepleted plasmas from Organon Teknika, Dade, Stago, Diagen and the Scottish National Blood Transfusion Service (SNBTS), and haemophilic plasma from Immuno were compared by several laboratories with haemophilic plasma from local donors as substrates in one-stage factor VIII assays. Five clinical plasma samples and four concentrates were assayed against British Standard plasma and International Standard concentrate.

Potencies of all plasma samples were not significantly different from those with local haemophilic plasma for Immuno, Organon Teknika, Stago and SNBTS substrates. Dade differed from haemophilic on one sample and Diagen on three. Buffer blank times and slopes of Standard lines were similar with all substrates. A positive drift between the beginning and end of the assay was found with the Immuno substrate and a negative drift with the Organon Teknika substrate.

In the concentrate study results for all substrate plasmas were not significantly different from haemophilic on the intermediate purity and conventional high purity products. On the monoclonal and recombinant products, there was a tendency for the immunodepleted substrates to give lower potencies than the haemophilic, and significant differences were found with Dade and Stago on the monoclonal concentrate, and with Dade, Stago and Diagen on the recombinant concentrate.

Overall, this study indicates that most commercially available substrate plasmas are suitable as replacements for locally collected haemophilic plasma in one-stage assays of clinical samples, and of intermediate purity and conventional high purity concentrates. For assays of very high purity concentrates (monoclonal and recombinant), haemophilic plasma is preferable as some immunodepleted plasmas give low results.

Members of the Thsk Force during this study were: J. E Davidson (Chairman), B. T Colvin (Secretary), T W. Barrowcliffe, P. B. A. Kernoff, S. J. Machin, E E. Prestofl, I. D. Walker

• References

• 1 Chantarangkul V, Ingram GIC, Thorn MB, Darby SC. An artificial haemophilic plasma for one-stage factor VIII assays. Br J Haematol 1978; 40: 471-488
  CrossrefPubMedGoogle Scholar
• 2 Ofosu FA, Cassidy K, Blajchman MA, Hirsh J. Immunodepletion of plasma factor VIII. Blood 1980; 56: 604-607
  PubMedGoogle Scholar
• 3 Trans TH, Duckert F. Preparation of factor VIII free plasma by immunoaffinity chromatography on insolubilized antibodies against factor Vlll-related antigen. Haemostasis 1983; 13: 73-77
  PubMedGoogle Scholar
• 4 Takase T, Rotblat F, Goodall AH, Kernoff PBA, Middleton S, Chand S, Denson KW, Austen DE, Tuddenham EGD. Production of factor VIII-deficient plasma by immunodepletion using three monoclonal antibodies. Br J Haematol 1987; 66: 497-502
  CrossrefPubMedGoogle Scholar
• 5 Hornsey VS, Waterston YG, Prowse CV. Artificial factor VIII-deficient plasma: preparation using monoclonal antibodies and its use in one-stage coagulation assays. J Clin Pathol 1988; 41: 562-567
  CrossrefPubMedGoogle Scholar
• 6 Rothschild C, Amiral J, Adam M, Meyer D. Preparation of factor VIII-depleted plasma with antibodies and its use in the assay of factor VIII. Haemostasis 1990; 20: 321-328
  PubMedGoogle Scholar
• 7 Dawson NJ, Kemball-Cook G, Barrowcliffe TW. Assay discrepancies with highly purified factor VIII concentrates. Haemostasis 1989; 19: 131-137
  PubMedGoogle Scholar
• 8 Finney DJ. Statistical Method in Biological Assay. 3.. Griffin; London: 1978
• 9 Cox DR. Combination of data. Encyclopaedia of Statistical Sciences. Vol 2 Kotz S, Johnson NL. (eds) John Wiley and Sons; New York: 1982. pp 45-52